Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A Locations section has been added with Arizona and Pennsylvania study sites (replacing the prior standalone Arizona Locations and Pennsylvania Locations blocks). The page revision is updated to v3.3.3, and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.4%
    Check dated 2025-12-23T10:16:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Only a minor revision/version update is shown (Revision: v3.3.2) in the page footer; no core content or study details appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:41:08.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.1 instead of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:45:15.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added related topics: Ovarian cancer and MedlinePlus Genetics to the study page. Removed a banner about government funding status and NIH operations.
    Difference
    0.6%
    Check dated 2025-11-17T07:17:00.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The MedlinePlus related topics section no longer lists 'Ovarian Cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-10T05:29:59.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    The page underwent a visual/UI refresh with a new header and updated formatting; no core content such as study title, NCT number, eligibility criteria, or outcomes changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:12.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.